News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Biotage AB: Interim Report January - March 2012
April 26, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Biotage (STO:BIOTA): First quarter 2012 · Group net sales increased by 12 percent to 119.6 MSEK (107.2). At comparable exchange rates sales increased by 8 percent.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Job Trends
10 Companies Hiring IT Professionals Now
January 29, 2026
·
2 min read
·
Angela Gabriel
Funding
Novo Foundation Pumps $850M Into Denmark, Europe to Bolster Innovation
January 16, 2026
·
2 min read
·
Tristan Manalac
Job Trends
3 Top Challenges Facing Manufacturing Professionals Right Now
January 15, 2026
·
6 min read
·
Angela Gabriel
Policy
Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech
January 13, 2026
·
3 min read
·
Annalee Armstrong
